Novavax COVID-19 Vaccine New Option for Adults

On July 20, CDC Director Rochelle P. Walensky, MD, MPH, endorsed the recommendation of the CDC Advisory Committee on Immunization Practices (ACIP) that Novavax’s COVID-19 vaccine be used as another primary series option for adults ages 18 years and older. Novavax’s COVID-19 vaccine, which will be available in the coming weeks, is an important tool in the pandemic and provides a more familiar type of COVID-19 vaccine technology for adults. Having multiple types of vaccines offers more options and flexibility for the public, jurisdictions, and vaccine providers.

CDC will conduct a Clinician Outreach and Communication Activity (COCA) call at 2 p.m. EDT on Thursday, July 28, to discuss CDC’s new guidance on the Novavax COVID-19 vaccine for adults ages 18 years and older.

A recording of the call will be available for viewing on the COCA Call webpage a few hours after the live event ends. The slide set will be available on the day of the call on the COCA Call webpage under Call Materials. Free Continuing Education (CE) will be offered for this COCA Call. Following is the participant information.

Participant Information
Dial-In: (646) 828-7666 (Audio Only)
Webinar ID: 161 272 8470
Passcode: 663869
Access Link: